4
Changes in Ownership
Medtronic plc Filed Acc 0001613103-25-000003
EVP & Pres Neuroscience sold 9,850 shares at $80.41 ($792,039)
- EVP & Pres Neuroscience acquired 6,850 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wall Brett A. EVP & Pres Neuroscience | 2025-01-08 | Option exercise 10b5-1 | +6,850 | $74.84 | $512,654 | 50,558 | D: show line 1 in the form |
| Wall Brett A. EVP & Pres Neuroscience | 2025-01-08 | Sale 10b5-1 | −6,850 | $80.41 | $550,809 | 43,708 | D: show line 2 in the form |
| Wall Brett A. EVP & Pres Neuroscience | 2025-01-08 | Sale 10b5-1 | −3,000 | $80.41 | $241,230 | 40,708 | D: show line 3 in the form |
| Open-market sales · 9,850 sh · avg $80.41 · $792,039 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Wall Brett A. EVP & Pres Neuroscience | 2025-01-08 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,850 | 0 | D: show line 4 in the form |
Loading xslF345X05/wk-form4_1736545728.xml…